Chinese spies stole COVID monoclonal antibody treatment among other secret methods from the US back in 2015. Alarmingly, even the coronavirus treatment science was among the things to be stolen. What this means is that even before COVID-19 broke out officially, atleast the US and China were already working on its treatment.
The US Department of Justice (DOJ) announced on Jan. 3 that a third former scientist at GlaxoSmithKline (GSK) has pleaded guilty to stealing trade secrets to the tune of $1 billion to benefit a pharmaceutical company which was backed by Chinese regime funding.
The third scientist employed by GlaxoSmithKline, Lucy Xi, pleaded guilty to stealing trade secrets – to boost a competing, state-funded Chinese pharmaceutical company. Trade secrets included the science behind COVID-19 treatments.
Lucy Xi, and her three co-defendants, established Renopharma (the Chinese pharmaceutical company). It was done with funding from the Chinese Communist Party to sup...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
